OR51I2
geneOn this page
Summary
OR51I2 (olfactory receptor family 51 subfamily I member 2, HGNC:15201) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 51I2 (Q9H344). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 390064 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001004754
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15201 |
| Approved symbol | OR51I2 |
| Name | olfactory receptor family 51 subfamily I member 2 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000187918 |
| Ensembl biotype | protein_coding |
| Entrez | 390064 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000641930
RefSeq mRNA: 1 — MANE Select: NM_001004754
NM_001004754
CCDS: CCDS31383
Canonical transcript exons
ENST00000641930 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003812328 | 5449323 | 5449364 |
| ENSE00003812604 | 5453259 | 5456518 |
Expression profiles
Bgee: expression breadth tissue_specific, 4 present calls, max score 78.73.
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibialis anterior | UBERON:0001385 | 78.73 | silver quality |
| ileal mucosa | UBERON:0000331 | 78.27 | silver quality |
| pancreatic ductal cell | CL:0002079 | 75.78 | silver quality |
| deltoid | UBERON:0001476 | 62.66 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| quadriceps femoris | UBERON:0001377 | 52.38 | gold quality |
| amniotic fluid | UBERON:0000173 | 51.71 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| vastus lateralis | UBERON:0001379 | 49.89 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| colonic epithelium | UBERON:0000397 | 46.97 | gold quality |
| skin of hip | UBERON:0001554 | 44.67 | silver quality |
| upper leg skin | UBERON:0004262 | 43.61 | silver quality |
| bone marrow | UBERON:0002371 | 43.57 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.78 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| bone marrow cell | CL:0002092 | 40.96 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 40.95 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.77 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 40.75 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.11 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or51i2 | ENSMUSG00000073932 |
| rattus_norvegicus | Or51i2 | ENSRNOG00000016964 |
Paralogs (51): OR51E2 (ENSG00000167332), OR51B5 (ENSG00000167355), OR51I1 (ENSG00000167359), OR51Q1 (ENSG00000167360), OR52A5 (ENSG00000171944), OR52W1 (ENSG00000175485), OR51B6 (ENSG00000176239), OR51V1 (ENSG00000176742), OR52E2 (ENSG00000176787), OR51L1 (ENSG00000176798), OR51G2 (ENSG00000176893), OR51A7 (ENSG00000176895), OR51T1 (ENSG00000176900), OR51S1 (ENSG00000176922), OR51F2 (ENSG00000176925), OR51E1 (ENSG00000180785), OR56B4 (ENSG00000180919), OR52E4 (ENSG00000180974), OR52N2 (ENSG00000180988), OR52N1 (ENSG00000181001), OR52N5 (ENSG00000181009), OR56B2 (ENSG00000181017), OR56B1 (ENSG00000181023), OR52N4 (ENSG00000181074), OR52P1 (ENSG00000181109), OR52D1 (ENSG00000181609), OR52H1 (ENSG00000181616), OR52K2 (ENSG00000181963), OR52A1 (ENSG00000182070), OR51B4 (ENSG00000183251), OR52E8 (ENSG00000183269), OR52L1 (ENSG00000183313), OR51M1 (ENSG00000184698), OR52B6 (ENSG00000187747), OR52K1 (ENSG00000196778), OR51D1 (ENSG00000197428), OR51C1 (ENSG00000197674), OR52M1 (ENSG00000197790), OR52E6 (ENSG00000205409), OR52J3 (ENSG00000205495)
Protein
Protein identifiers
Olfactory receptor 51I2 — Q9H344 (reviewed: Q9H344)
Alternative names: Odorant receptor HOR5’beta12, Olfactory receptor OR11-38
All UniProt accessions (2): A0A126GVE9, Q9H344
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004754* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050402 | OR51/52/56-like | Family |
Pfam: PF13853
UniProt features (22 total): topological domain 8, transmembrane region 7, sequence variant 4, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H344-F1 | 90.87 | 0.71 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 19 (showing top):
GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_RESPONSE_TO_LIPID, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, NCOA4_TARGET_GENES, REACTOME_SENSORY_PERCEPTION
GO Biological Process (6): sensory perception of smell (GO:0007608), cellular response to lipid (GO:0071396), system process (GO:0003008), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), signaling receptor activity (GO:0038023)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of chemical stimulus | 1 |
| response to lipid | 1 |
| cellular response to chemical stimulus | 1 |
| multicellular organismal process | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| molecular transducer activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
202 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR51I2 | KRTAP12-3 | P60328 | 593 |
| OR51I2 | GARIN2 | Q8N9W8 | 545 |
| OR51I2 | TMEM235 | A6NFC5 | 541 |
| OR51I2 | WDR38 | Q5JTN6 | 492 |
| OR51I2 | TAS2R41 | P59536 | 477 |
| OR51I2 | C1QTNF8 | P60827 | 447 |
| OR51I2 | NWD1 | Q149M9 | 425 |
| OR51I2 | SNAPC4 | Q5SXM2 | 413 |
| OR51I2 | EMC4 | Q5J8M3 | 406 |
| OR51I2 | SPATA31D3 | P0C874 | 399 |
| OR51I2 | LVRN | Q6Q4G3 | 383 |
| OR51I2 | TMEM132C | Q8N3T6 | 383 |
| OR51I2 | NPBWR2 | P48146 | 370 |
| OR51I2 | DDX49 | Q9Y6V7 | 364 |
| OR51I2 | SPATA31D4 | Q6ZUB0 | 356 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A3B3IT45, A6NGY5, O88628, P0C646, Q6IFG1, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGH6, Q8NGH7, Q8NGH9, Q8NGI0, Q8NGI2, Q8NGJ2, Q8NGJ3, Q8NGJ4, Q8NGJ5, Q8NGJ6, Q8NGJ7, Q8NGJ9, Q8NGK1, Q8NGK2, Q8NGK3, Q8NGK4, Q8NGK5, Q8NGK6, Q8NH53, Q8NH55, Q8NH56, Q8NH57, Q8NH59, Q8NH60, Q8NH61, Q8NH63, Q8NH64, Q8TCB6, Q8VBV9, Q96RD2, Q96RD3, Q9H255
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
364 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:5450989:A:AC | donor_gain | 0.9000 |
| 11:5455172:T:TG | acceptor_gain | 0.7600 |
| 11:5455746:A:T | acceptor_gain | 0.7300 |
| 11:5454142:T:TA | acceptor_gain | 0.7200 |
| 11:5454365:A:AG | acceptor_gain | 0.7100 |
| 11:5454366:G:GG | acceptor_gain | 0.7100 |
| 11:5450927:T:C | acceptor_gain | 0.6900 |
| 11:5451763:T:TC | acceptor_gain | 0.6900 |
| 11:5453979:A:G | acceptor_gain | 0.6900 |
| 11:5454141:AT:A | acceptor_gain | 0.6800 |
| 11:5454142:T:G | acceptor_gain | 0.6700 |
| 11:5454366:GC:G | acceptor_gain | 0.6700 |
| 11:5453588:AT:A | donor_gain | 0.6500 |
| 11:5454364:TAGCG:T | acceptor_loss | 0.6500 |
| 11:5454366:G:GT | acceptor_loss | 0.6500 |
| 11:5450927:TTAAA:T | acceptor_gain | 0.6300 |
| 11:5454023:T:A | acceptor_gain | 0.6300 |
| 11:5454141:ATGT:A | acceptor_gain | 0.6200 |
| 11:5454343:T:TA | acceptor_gain | 0.6200 |
| 11:5454364:T:G | acceptor_gain | 0.6100 |
| 11:5450793:C:CA | donor_gain | 0.6000 |
| 11:5453837:GCCA:G | donor_gain | 0.6000 |
| 11:5454283:G:T | donor_gain | 0.6000 |
| 11:5451763:T:C | acceptor_gain | 0.5900 |
| 11:5454141:A:AG | acceptor_gain | 0.5900 |
| 11:5454365:AGC:A | acceptor_gain | 0.5900 |
| 11:5454366:GCG:G | acceptor_gain | 0.5900 |
| 11:5453545:TCTG:T | donor_gain | 0.5800 |
| 11:5453980:GA:G | acceptor_gain | 0.5800 |
| 11:5454109:T:TA | acceptor_gain | 0.5800 |
AlphaMissense
2053 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:5453843:A:C | S119R | 0.960 |
| 11:5453845:T:A | S119R | 0.960 |
| 11:5453845:T:G | S119R | 0.960 |
| 11:5453942:A:C | S152R | 0.949 |
| 11:5453944:C:A | S152R | 0.949 |
| 11:5453944:C:G | S152R | 0.949 |
| 11:5454239:T:C | F251L | 0.933 |
| 11:5454241:T:A | F251L | 0.933 |
| 11:5454241:T:G | F251L | 0.933 |
| 11:5453842:G:A | M118I | 0.929 |
| 11:5453842:G:C | M118I | 0.929 |
| 11:5453842:G:T | M118I | 0.929 |
| 11:5453693:A:C | S69R | 0.910 |
| 11:5453695:T:A | S69R | 0.910 |
| 11:5453695:T:G | S69R | 0.910 |
| 11:5453685:T:C | L66S | 0.906 |
| 11:5453792:T:C | F102L | 0.900 |
| 11:5453794:T:A | F102L | 0.900 |
| 11:5453794:T:G | F102L | 0.900 |
| 11:5453853:G:C | R122P | 0.895 |
| 11:5453850:A:T | D121V | 0.881 |
| 11:5454073:C:A | N195K | 0.879 |
| 11:5454073:C:G | N195K | 0.879 |
| 11:5454150:T:C | I221T | 0.875 |
| 11:5453850:A:C | D121A | 0.872 |
| 11:5454278:T:C | F264L | 0.870 |
| 11:5454280:T:A | F264L | 0.870 |
| 11:5454280:T:G | F264L | 0.870 |
| 11:5454352:C:A | N288K | 0.870 |
| 11:5454352:C:G | N288K | 0.870 |
dbSNP variants (sampled 300 via entrez): RS1000062382 (11:5450727 T>C), RS1000396087 (11:5450789 A>T), RS1000407414 (11:5450518 G>A,T), RS1001240423 (11:5450164 A>G), RS1001943014 (11:5451016 A>G,T), RS1002059610 (11:5456006 T>C), RS1002141931 (11:5451969 AAAT>A), RS1002299353 (11:5456265 C>A,T), RS1002410456 (11:5456313 G>C), RS1002787861 (11:5447518 T>C), RS1002851102 (11:5452233 G>A,C,T), RS1003367486 (11:5453222 G>A), RS1003802482 (11:5448404 T>A), RS1003809537 (11:5453168 G>A,T), RS1003966135 (11:5447813 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001862_2 | Sickle cell anemia (haemolysis) | 3.000000e-10 |
| GCST009184_7 | Inferior parietal cortex volume | 4.000000e-06 |
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Grape Seed Proanthocyanidins | decreases expression, affects cotreatment | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): sickle cell disease